FATTY LIVER, NONALCOHOLIC
Clinical trials for FATTY LIVER, NONALCOHOLIC explained in plain language.
Never miss a new study
Get alerted when new FATTY LIVER, NONALCOHOLIC trials appear
Sign up with your email to follow new studies for FATTY LIVER, NONALCOHOLIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Diabetes pill shows promise against fatty liver
Disease control CompletedThis study looked at whether a class of diabetes drugs called SGLT2 inhibitors can improve fatty liver disease in people with type 2 diabetes. 150 adults with both conditions took the medication for 6 months. Researchers measured changes in liver stiffness, fat levels, and blood …
Matched conditions: FATTY LIVER, NONALCOHOLIC
Phase: PHASE3 • Sponsor: Sohag University • Aim: Disease control
Last updated May 26, 2026 08:41 UTC
-
Oranges show promise for fatty liver control
Disease control CompletedThis study looked at whether eating oranges can improve how the body handles fats and sugars in people with Metabolic Associated Fatty Liver Disease (MAFLD). Researchers gave oranges to 60 adults aged 30-65 with MAFLD and measured changes in liver fat and blood markers. The goal …
Matched conditions: FATTY LIVER, NONALCOHOLIC
Phase: NA • Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis • Aim: Disease control
Last updated May 26, 2026 08:20 UTC
-
VR diet coach tested for fatty liver
Disease control CompletedThis study tested a virtual reality (VR) diet program for adults with fatty liver disease. 20 participants used the VR program along with video counseling to learn about healthy eating and weight loss. The goal was to see if this approach is practical and can help people lose wei…
Matched conditions: FATTY LIVER, NONALCOHOLIC
Phase: NA • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New drug shows promise in reversing fatty liver damage
Disease control CompletedThis study tested a new medicine called efinopegdutide in 381 adults with non-alcoholic steatohepatitis (NASH), a serious liver condition. The main goal was to see if the drug could stop signs of NASH without making liver scarring worse. Researchers also checked for side effects …
Matched conditions: FATTY LIVER, NONALCOHOLIC
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 20, 2026 11:53 UTC